Literature DB >> 20437874

Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.

Filippo Pietrantonio1, Maria Di Bartolomeo, Roberto Buzzoni, Emilio Bajetta.   

Abstract

Drug-induced acute thrombocytopenia is an extremely rare side effect that may occur immediately after oxaliplatin infusion. This potentially fatal reaction is immune mediated and can be anticipated by mild hemorrhagic signs during previous administrations. This is the first report of acute thrombocytopenia occurring during adjuvant treatment of colorectal cancer with oxaliplatin. Clinicians should be aware of this adverse event in order to prevent possible serious consequences and stop further oxaliplatin administration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20437874     DOI: 10.1177/030089161009600125

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  3 in total

1.  Oxaliplatin-induced acute-onset thrombocytopenia and hemorrhage: Case report and review of the literature.

Authors:  Shoichiro Ohta; Yukiko Cho; Shinji Oshima; Osamu Hosoya; Kazuhiko Juni; Hiroshi Kojima
Journal:  Oncol Lett       Date:  2012-03-23       Impact factor: 2.967

2.  Thrombocytopenia in Patients Receiving Prolonged Linezolid May be Caused by Oxidative Stress.

Authors:  Tian-Lin Wang; Dai-Hong Guo; Yan Bai; Ke Wen; Wen-Yan Han; Rui Wang
Journal:  Clin Drug Investig       Date:  2016-01       Impact factor: 2.859

Review 3.  Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.

Authors:  Jui-Ho Wang; Tai-Ming King; Min-Chi Chang; Chao-Wen Hsu
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.